AU2004318681A1 - Nucleic acid based assays for identification of FC receptor polymorphisms - Google Patents

Nucleic acid based assays for identification of FC receptor polymorphisms Download PDF

Info

Publication number
AU2004318681A1
AU2004318681A1 AU2004318681A AU2004318681A AU2004318681A1 AU 2004318681 A1 AU2004318681 A1 AU 2004318681A1 AU 2004318681 A AU2004318681 A AU 2004318681A AU 2004318681 A AU2004318681 A AU 2004318681A AU 2004318681 A1 AU2004318681 A1 AU 2004318681A1
Authority
AU
Australia
Prior art keywords
primers
genotype
nucleic acids
combination
oligonucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004318681A
Other languages
English (en)
Inventor
Pablo G. Garcia
Susan E. Wilson
Gene Guozhong Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Novartis Vaccines and Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines and Diagnostics Inc filed Critical Novartis Vaccines and Diagnostics Inc
Publication of AU2004318681A1 publication Critical patent/AU2004318681A1/en
Assigned to NOVARTIS VACCINES AND DIAGNOSTICS, INC. reassignment NOVARTIS VACCINES AND DIAGNOSTICS, INC. Request for Assignment Assignors: CHIRON CORPORATION
Assigned to NOVARTIS VACCINES AND DIAGNOSTICS, INC. reassignment NOVARTIS VACCINES AND DIAGNOSTICS, INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: CHIRON CORPORATION
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2004318681A 2004-04-07 2004-12-22 Nucleic acid based assays for identification of FC receptor polymorphisms Abandoned AU2004318681A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56064904P 2004-04-07 2004-04-07
US60/560,649 2004-04-07
PCT/US2004/043726 WO2005102379A2 (en) 2004-04-07 2004-12-22 Nucleic acid based assays for identification of fc receptor polymorphisms

Publications (1)

Publication Number Publication Date
AU2004318681A1 true AU2004318681A1 (en) 2005-11-03

Family

ID=35197498

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004318681A Abandoned AU2004318681A1 (en) 2004-04-07 2004-12-22 Nucleic acid based assays for identification of FC receptor polymorphisms

Country Status (10)

Country Link
EP (1) EP1732939A4 (pt)
JP (1) JP2007532110A (pt)
KR (1) KR20070004082A (pt)
CN (1) CN1976942A (pt)
AU (1) AU2004318681A1 (pt)
BR (1) BRPI0418722A (pt)
CA (1) CA2562016A1 (pt)
IL (1) IL178333A0 (pt)
RU (1) RU2006138865A (pt)
WO (1) WO2005102379A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090181016A1 (en) * 2005-11-30 2009-07-16 University Of Southern California FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME
EP2109686A2 (en) 2007-01-18 2009-10-21 University Of Southern California Genetic markers for predicting responsiveness to combination therapy
WO2009026502A1 (en) * 2007-08-22 2009-02-26 Wyeth Nested pcr-based method for specific genotyping of the fc-gamma receptor iiia gene
JP2016534749A (ja) * 2013-10-15 2016-11-10 コネクシオ ゲノミクス ピーティーワイ リミテッド 主要組織適合遺伝子複合体一塩基多型
WO2021146521A1 (en) * 2020-01-16 2021-07-22 Acepodia Biotechnologies Ltd. A novel cd16+ natural killer cell and a method of culturing cd16+ natural killer cell
CN114277149B (zh) * 2021-12-30 2023-09-22 苏州方科生物科技有限公司 一种检测cd16a基因多态性的试剂盒及其应用和使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639611A (en) * 1988-12-12 1997-06-17 City Of Hope Allele specific polymerase chain reaction
AU2002346999B2 (en) * 2001-10-19 2007-11-08 Centre Hospitalier Regional Et Universitaire De Tours Methods and compositions to evaluate antibody treatment response

Also Published As

Publication number Publication date
JP2007532110A (ja) 2007-11-15
EP1732939A2 (en) 2006-12-20
EP1732939A4 (en) 2008-09-17
CN1976942A (zh) 2007-06-06
RU2006138865A (ru) 2008-05-20
KR20070004082A (ko) 2007-01-05
IL178333A0 (en) 2007-02-11
WO2005102379A2 (en) 2005-11-03
CA2562016A1 (en) 2005-11-03
BRPI0418722A (pt) 2007-09-11
WO2005102379A3 (en) 2006-02-16

Similar Documents

Publication Publication Date Title
US10801078B2 (en) Methods and compositions for detecting BK virus
WO2012061814A1 (en) Pcr primers and methods for rapid and specific genotyping
US20210011019A1 (en) Mpl mutations in jak2 v617f negative patients with myeloproliferative disease
AU2015358251A1 (en) Methods and reagents for detecting neisseria gonorrhoeae and its antimicrobial resistance determinants
CZ20033516A3 (cs) Diagnostické zkoušky pro parvovirus B19
MXPA04012501A (es) Identificacion de oligonucleotidos para la captura, deteccion y cuatificacion de acido nucleico viral de la hepatitis a.
AU2004318681A1 (en) Nucleic acid based assays for identification of FC receptor polymorphisms
KR101724130B1 (ko) 장 베체트병 진단용 바이오마커 및 이의 용도
JP2008529523A (ja) 一塩基多型を含む乳癌に関連したポリヌクレオチド、それを含むマイクロアレイ及び診断キット、並びにそれを利用した乳癌の診断方法
JP6128654B2 (ja) 関節リウマチの新規遺伝因子としてのミエリン塩基性蛋白の利用
JPWO2013157625A1 (ja) Ｈｌａ−ａ＊２４：０２を検出する方法、及び検出キット
JP4657857B2 (ja) メタボリックシンドロームの診断および予防
MXPA06011476A (en) Nucleic acid based assays for identification of fc receptor polymorphisms
KR102409336B1 (ko) 면역글로불린 a 신병증 및 혈관염 진단용 snp 마커 및 이를 이용한 진단 방법
AU2012261529A1 (en) Methods and compositions for detecting BK virus
JP2006101847A (ja) 気管支喘息の遺伝的素因検査方法

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC.

Free format text: FORMER APPLICANT(S): CHIRON CORPORATION

TH Corrigenda

Free format text: IN VOL 22, NO 25, PAGE(S) 2951 UNDER THE HEADING ASSIGNMENTS BEFORE GRANT, SECTION 113 - 2004 UNDERTHE NAME NOVARTIS VACCINES AND DIAGNOSTICS, INC. DELETE ALL REFERENCE TO 2004318681

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application